Allogeneic hematopoietic stem cell transplantation is the only possible treatment for many malignant and non-malignant hemopathies. The graft-versus-host immunological reaction (GvH) is a frequent and sometimes serious complication. The objective is to study whether a systematic and early follow-up by a lung specialist of allografted patients would allow an earlier diagnosis of GvH with pulmonary complications.
Study Type
OBSERVATIONAL
Enrollment
227
Hematopoietic stem cell transplantation
Croix-Rousse Hospital, Hospices Civils de Lyon
Lyon, France
Medical complications
100 days after allograft
Time frame: Medical complications, especially Graft-versus-Host reaction with pulmonary complications occurring within 100 days post-surgery are studied
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.